Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Wang Website

Xin Wei Wang, Ph.D.

Selected Publications

1)  Roessler S, Budhu A, Wang XW.
Deciphering cancer heterogeneity: the biological space.
Front Cell Dev Biol. 2: 12, 2014.
Full Text Article. [Journal]
2)  Yamashita T, Kitao A, Matsui O, Hayashi T, Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, Mizukoshi E, Honda M, Nakanuma Y, Takamura H, Ohta T, Nakamoto Y, Yamamoto M, Takayama T, Arii S, Wang XW, Kaneko S.
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Hepatology. [Epub ahead of print], 2014.
[Journal]
3)  Parpart S, Roessler S, Dong F, Rao V, Takai A, Ji J, Qin L, Ye Q, Jia H, Tang Z, Wang XW.
Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome.
Hepatology. [Epub ahead of print], 2014.
[Journal]
4)  Dang HT, Budhu A, Wang XW.
The origin of cancer stem cells.
J. Hepatol. [Epub ahead of print], 2014.
[Journal]
5)  Yamashita T, Wang XW.
Cancer stem cells in the development of liver cancer.
J. Clin. Invest. 123: 1911-8, 2013.
[Journal]
6)  Ji J, Yu L, Yu Z, Forgues M, Uenishi T, Kubo S, Wakasa K, Zhou J, Fan J, Tang ZY, Fu S, Zhu H, Jin JG, Sun HC, Wang XW.
Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma.
Int. J. Biol. Sci. 9: 303-12, 2013.
[Journal]
7)  Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, Kaneko S.
Discrete nature of EpCAM(+) and CD90(+) cancer stem cells in human hepatocellular carcinoma.
Hepatology. 57: 1484-97, 2013.
[Journal]
8)  Zhu WW, Guo JJ, Guo L, Jia HL, Zhu M, Zhang JB, Loffredo CA, Forgues M, Huang H, Xing XJ, Ren N, Dong QZ, Zhou HJ, Ren ZG, Zhao NQ, Wang XW, Tang ZY, Qin LX, Ye QH.
Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma.
Clin. Cancer Res. 19: 3944-3954, 2013.
[Journal]
9)  Henrich CJ, Budhu A, Yu Z, Evans JR, Goncharova EI, Ransom TT, Wang XW, McMahon JB.
High-throughput Screening for Identification of Inhibitors of EpCAM-Dependent Growth of Hepatocellular Carcinoma Cells.
Chem Biol Drug Des. 82: 131-9, 2013.
[Journal]
10)  Hsiao TH, Chen HI, Roessler S, Wang XW, Chen Y.
Identification of genomic functional hotspots with copy number alteration in liver cancer.
EURASIP J Bioinform Syst Biol. 2013: 14, 2013.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/19/2014.